MedPath

RCT Comparing OAGB and Long Limb Roux Gastric Bypass

Not Applicable
Recruiting
Conditions
Obesity
Interventions
Procedure: One-anastomosis gastric bypass
Procedure: Long biliary limb Roux gastric bypass
Registration Number
NCT04812132
Lead Sponsor
Tartu University Hospital
Brief Summary

A prospective multicenter randomized controlled trial to compare the outcomes of one-anastomosis gastric bypass to long biliary limb Roux gastric bypass.

We plan to enroll up to 500 patients from three different clinics in Estonia. Outcomes are excess weight loss %, impact on type 2 diabetes, hypertension, hyperlipidemia and obstructive sleep apnea.

Other outcomes are nutritional deficiencies, occurrence of reflux disease and impact on quality of life.

There are planned outpatient visits 1, 5 and 10 years after the surgery to measure the impacts.

There are a lot of studies comparing OAGB to standard Roux gastric bypass but non comparing it to long biliary limb gastric bypass.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • BMI over 35 and obesity related disease
  • BMI over 40
  • age between 18-60 years
  • agrees to participate in the study
Read More
Exclusion Criteria
  • age under 18 years or over 60 years
  • abundant adhesions discovered during the surgery
  • active upper gastrointestinal ulcer disease
  • prior bariatric surgery
  • active symptomatic reflux disease
  • active psychiatric disease (eg psychosis)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MenOne-anastomosis gastric bypass-
WomenLong biliary limb Roux gastric bypass-
MenLong biliary limb Roux gastric bypass-
WomenOne-anastomosis gastric bypass-
Primary Outcome Measures
NameTimeMethod
Impact on total cholesterol10 years

Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol (mmol/L).

Impact on hypertensive disease10 years

Outcome of hypertensive disease after the surgery; measured in antihypertensive drug usage (same, decrease, ended)

Impact on type 2 diabetes mellitus10 years

Outcome of type 2 diabetes mellitus after the surgery, measured in usage of medication (same dosage, decreased dosage, insulin to peroral, ended all medication)

Impact on hyperlipidemia10 years

Outcome of hyperlipidemias after the surgery, measured in change in levels of triglycerides (mmol/L)

Impact on hyperlipidemias10 years

Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol, HDL,LDL and triglycerides

Excess weight loss %10 years

Calculated loss of the excess weight

Secondary Outcome Measures
NameTimeMethod
Nutritional deficiencies: anemia10 years

% of subjects having hemoglobin below sex adjusted reference (g/L) and ferritin below sex adjusted references (ug/L)

GERD10 years

% of subjects reporting reflux disease symptoms and/or PPI usage after the surgery

Nutritional deficiencies10 years

Occurrence of B12 deficiency, measured in % of subjects with vitamin B12 below reference (measures in pmol/L)

Trial Locations

Locations (1)

Tartu University Hospital

🇪🇪

Tartu, Estonia

© Copyright 2025. All Rights Reserved by MedPath